Waltham, United States
Biomodels is a preclinical contract research organization that specializes in developing and executing predictive and highly translational efficacy studies for biotechnology and pharmaceutical companies. With over a decade of experience, the company is dedicated to providing personalized service, customized solutions, and clinically relevant disease models. Their state-of-the-art research facility and vivarium house leading technologies including HD video endoscopy, IVIS in-vivo imaging, X-ray radiation source, FlexiVent system for measurement of pulmonary function, MACSQuant for FACS analysis and cell separation, RT-PCR, microscopy, and behavioral analysis equipment. These resources, combined with their in-house scientists, lab personnel, and strategic partnerships, ensure meticulous study design and execution.
Founded in 1997 and headquartered in the United States, Biomodels has positioned itself at the forefront of the biotechnology and pharmaceutical industries. While specific details regarding their last investment and investors are currently unavailable, the company's commitment to cutting-edge research and comprehensive preclinical services demonstrates significant potential for continued growth and success in the market. As the demand for advanced preclinical research services continues to rise, Biomodels is well-positioned to capitalize on this opportunity and establish itself as a key player in the industry.
